✦ LIBER ✦

Cyclin-dependent kinase inhibitors-A novel class of prognostic indicators

✍ Scribed by Juan P. Palazzo

Book ID: 117818489
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 37 KB
Volume: 32
Category: Article
ISSN: 1532-8392
DOI: 10.1053/hupa.2001.27822

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design of a Novel Class of Peptide Inhib

Design of a Novel Class of Peptide Inhibitors of Cyclin-dependent Kinase/Cyclin Activation

✍ Gondeau, C.; Gerbal-Chaloin, S.; Bello, P.; Aldrian-Herrada, G.; Morris, M. C.; 📂 Article 📅 2005 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 903 KB

Indenopyrazoles as Novel Cyclin Dependen

Indenopyrazoles as Novel Cyclin Dependent Kinase (CDK) Inhibitors

✍ Nugiel, David A.; Etzkorn, Ana-Marie; Vidwans, Anup; Benfield, Pamela A.; Boiscl 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 36 KB

Characterization of Novel Inhibitors of

Characterization of Novel Inhibitors of Cyclin-Dependent Kinases

✍ Lorraine L. Kent; Nicolina E. Hull-Campbell; Ted Lau; John C. Wu; Stewart A. Tho 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Biochemical and cellular effects of a no

Biochemical and cellular effects of a novel cyclin-dependent kinase inhibitor

✍ R. Jorda; V. Krystof; L. Havlícek; M. Strnad 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 89 KB

THE PROGNOSTIC SIGNIFICANCE OF ALTERED C

THE PROGNOSTIC SIGNIFICANCE OF ALTERED CYCLIN-DEPENDENT KINASE INHIBITORS IN HUMAN CANCER

✍ Tsihlias, MD, FRCSC, J.; Kapusta, MD, FRCPC, L.; Slingerland, MD, FRCPC, PhD, J. 📂 Article 📅 1999 🏛 Annual Reviews 🌐 English ⚖ 574 KB

Inhibitors of cyclin-dependent kinase an

Inhibitors of cyclin-dependent kinase and cancer

✍ J. R. Biggs; A. S. Kraft 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 621 KB

Recent research has yielded a dramatic increase in the number of connections between oncogenesis and the proteins which regulate the cell cycle. Three classes of protein which inhibit the activity of cyclin-dependent kinases (CDKs) have emerged as potential targets for oncogenic inactivation. p16 an